Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

10 nov. 2025 07h25 HE | Source: Dyadic International, Inc.

Dyadic Applied BioSolutions Expands Genetic Engineering Capabilities Through CRISPR/Cas9 Commercial License with ERS Genomics

Dyadic Applied BioSolutions Expands Genetic Engineering Capabilities Through CRISPR/Cas9 Commercial License with ERS Genomics
13 janv. 2025 09h00 HE | Source: ERS Genomics

ERS Genomics launches ‘Express License’ platform to democratise access to CRISPR/Cas9

ERS Genomics (‘ERS’), the CRISPR licensing company, today announces the launch of its Express License platform.
30 mai 2017 12h20 HE | Source: Taconic Biosciences

Taconic Biosciences Secures CRISPR License From ERS Genomics

HUDSON, N.Y., May 30, 2017 (GLOBE NEWSWIRE) -- Taconic Biosciences, a global leader in genetically engineered mouse models and associated services, announced it has signed a license agreement with...
16 déc. 2016 08h00 HE | Source: CRISPR Therapeutics AG

CRISPR Therapeutics, Intellia Therapeutics, Caribou Biosciences and ERS Genomics Announce Global Agreement on the Foundational Intellectual Property for CRISPR/Cas9 Gene Editing Technology

BASEL, Switzerland, CAMBRIDGE, Mass., BERKELEY, Calif. and DUBLIN, Ireland, Dec. 16, 2016 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (NASDAQ:CRSP), Intellia Therapeutics (NASDAQ:NTLA), Caribou...